Background: We evaluated the role of oxidative stress in diabetic nephropathy by measuring intracellular
. Intracellular ROS in PBMC isolated from healthy control subject, diabetic patients without nephropathy, and patients with diabetic nephropathy. Fig. 1 
Electrophoretic Mobility Shift Assay (EMSA)
10 μg의 핵단백을 사용하여 EMSA를 시행 하였으며,
Fig. 2. The specificity of oligonucleotides for NF-κB, AP-1 and Sp1. In order to evaluate the reliability of this study, we analyzed the specificity of oligonucleotide for NF-κB, AP-1 and Sp1 by competetion EMSA with labeled and unlabeled ("cold") oligonucleotides, respectively. The band formed from interaction between nuclear extract and labeled NF-κB disappeared when "cold NF-κB" was added, and the same effect was seen with AP-1 and Sp1, thus showing the specificity of oligonucleotides for NF-κB, AP-1 and Sp1. * P < 0.05, compared to group I. †P < 0.05, compared to group II. Group I, Normal healthy control; Group II, Diabetic patients without nephropathy; Group III, Diabetic patients with nephropathy; ROS, reactive oxygen species; UAE, urine albumin excretion. These table show that there was significant increment in H2O2-and PMA-induced ROS levels in patients with nephropathy, versus those without nephropathy (21.8 ± 2.2 vs. 11.1 ± 2.0%, 23.5 ± 4.5 vs. 21.6 ± 2.2%, respectively, all P < 0.05). , and Sp1 in PBMC in different groups. Activities of transcription factors were quantified using EMSA and densitometry (Biorad). * P < 0.05, compared to group I, †P < 0.05, compared to group II.
Group I, Normal healthy control; Group II, Diabetic patients without nephropathy; Group III, Diabetic patients with nephropathy; UAE, urine albumin excretion. Group I, Normal healthy control; Group II, Diabetic patients without nephropathy; Group III, Diabetic patients with nephropathy; PBMC-TGF-β1, TGF-β1 in PBMC; uTGF-β1, urinary TGF-β1. The expression of TGF-β1 in PBMC and urine was significantly higher in patients with diabetic nephropathy than in diabetic patients without nephropathy. * P < 0.05, compared to group I. †P < 0.05, compared to group II. Group I, Normal healthy control; Group II, Diabetic patients without nephropathy; Group III, Diabetic patients with nephropathy; PBMC-TGF-β1, TGF-β1 in PBMC; uTGF-β 1, urinary TGF-β1. The expression of TGF-β1 in PBMCs and urine was higher in patients with diabetic nephropathy than in diabetic patients without nephropathy (3.2265 ± 0.3901 vs. 1.9921 ± 0.6785; 16.8758 ± 6.8399 vs. 5.6069 ± 1.5696, all P < 0.05), however, no difference was found in urinary or PBMC-TGF-β1 between normal healthy control and diabetic patients without nephropathy. 활성도는 비슷하였다 (Table 3) (Fig. 3) . . PBMC-TGF-β1: TGF-β1 in PBMC; uTGF-β1: urinary TGF-β1; ROD: Relative optical density. Urinary TGF-β1 protein was significantly correlated with 24-hour albumin excretion (r = 0.729, P = 0.001). Moreover, the expression of TGF-β1 was not found to be significantly correlated with the Sp1 activity, but was significantly correlated with NF-κB and AP-1 activities (r = 0.786, r = 0.826, respectively, all P < 0.001).
Fig. 6.
Correlations between 24 h UAE and PBMC-TGF-β1 (A), activity of NF-κB and PBMC-TGF-β1 (B), activity of AP-1 and PBMC-TGF-β1 (C), and activity of Sp1 and PBMC-TGF-β1 (D). PBMC-TGF-β1: TGF-β1 in PBMC; uTGF-β1: urinary TGF-β1; ROD: Relative optical density. TGF-β1 protein in PBMC was found to be significantly correlated with 24-hour albumin excretion, NF-κB, and AP-1 activities (r = 0.694, r = 0.797, r = 0.086, respectively, all P = 0.001), but was not correlated with Sp1 activity (r = 0.549, P = 0.071). 참 고 문 헌 EMBO J 12:3879-91, 1993 33. Sen CK, Packer L: Antioxidant and redox regulation of gene transcription. FASEB J 10:709-20, 1996 Perit Dial Int 19:S234-7, 1999 
